“`html
HCA Healthcare Inc (Symbol: HCA) shares have surpassed the average 12-month analyst target price of $237.89, trading at $239.37 per share. This movement prompts analysts to consider whether to downgrade their valuations or adjust target prices higher, depending on the company’s fundamental developments.
There are 19 analysts covering HCA, with targets ranging from a low of $160.00 to a high of $275.00, resulting in a standard deviation of $24.71. The current breakdown of analyst ratings includes 13 strong buys, 2 buys, 2 holds, and 1 strong sell, reflecting a stable investor sentiment towards the stock.
The average rating for HCA is 1.56, where 1 indicates a strong buy and 5 a strong sell. These insights highlight the potential for upward adjustments in target prices as investors reassess HCA’s value following its recent price movements.
“`
